Bleeding tendency of unknown origin and protein Z levels

Thrombosis Research

Volumn 90, Issue 6, 1998, Pages 291-295

  Gamba, Gabriella ^a   Bertolino, Giampiera ^a   Montani, Nadia ^a   Spedini, Pierangelo ^a   Balduini, Carlo L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Bleeding tendency; Protein Z; Warfarin therapy

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; BLOOD CLOTTING; CALCIUM CELL LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; BLEEDING TIME; BLOOD COAGULATION TESTS; BLOOD PROTEINS; CHILD; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PLATELET AGGREGATION; WARFARIN;

EID: 0032526835     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00036-X     Document Type: Article

References (12)

1. Hojrup P., Jensen M.S., Petersen T.E. Amino-acid sequence of bovine protein Z. A vitamin K-dependent serine protease homology FEBS Letters. 184:1985;333-338.
2. Hogg J.H., Stenflo J. Interaction of vitamin K-dependent protein Z with thrombin. Consequence for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles. J Biol Chem. 266:1991;10953-10958.
3. Miletich J.P., Broze G.J. Human plasma protein Z antigen. Range in normal subjects and effect of warfarin therapy Blood. 69:1987;1580-1586.
4. Yurdakok M., Gurakan B., Ozbag E., Vigit S., Dundar S., Kirazli S. Plasma protein Z levels in healthy newborn infants. Am J Hematol. 48:1995;206-207.
5. Kemkes-Matthes B., Matthes K.J. Protein Z, a new haemostatic factor, in liver disease. Haemostasis. 25:1995;312-316.
6. Prowse V.C., Esnouf M.P. The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans. 5:1977;255-256.
7. Kemkes-Matthes B., Matthes K.J. Protein Z deficiency. A new cause of bleeding tendency Thromb Res. 79:1995;49-55.
8. Balduini C.L., Sinigaglia F., Damiani G., Bertolino G., Bisio A., Zocchi E. Effect of a monoclonal antibody against GPs IIb-IIIa on platelet aggregation and ATP secretion. Exp Hematol. 14:1986;338-342.
9. Born G.V.R. Aggregation of blood by adenosine-diphosphate and its reversal. Nature. 194:1962;927-929.
10. White G.C. II, Marder V.J., Colman R.W., Hirsh J., Salzman E.W. Approach to the bleeding patient. Colman R.W., Hirsh J., Marder V.J., Salzman E.W. Haemostasis and Thrombosis. Basic Principle and Clinical Practice. 3:1994;1134-1147 Lippincott Company, Philadelphia.
11. von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's Organization. Definition, inheritance, clinical features and diagnosis of von Willebrand Disease. Guidelines for the Diagnosis and Management of von Willebrand Disease. Haemophilia (Suppl 2) 1997:1-3.
12. Bertolino G, Montani N, Lorenzutti F, Balduini CL, Gamba G. Behaviour of plasma protein Z levels in patients with abnormal haemostasis: Correlations with coagulation screening tests. Thromb Haemost (Suppl) 1997:235.